Epitalon
Also known as: Epithalon, Epithalamin
At a Glance
Epitalon (also seen as epithalon/epithalamin in some sources) is discussed in longevity-related contexts. One frequently cited line of evidence is cell-culture work reporting increased telomerase activity and telomere length under specific experimental conditions. [PMID: 12937682]
⚠️ Research Status: Epitalon is not an approved medication. This page is educational and intentionally does not include protocols/dosing.
Mechanism of Action (TBD)
Mechanistic claims often focus on telomerase/telomere biology; treat these as experimental findings until supported by replicated primary sources in relevant models. [PMID: 12937682]
Evidence Summary
Telomerase/Telomeres (Cell Models)
Low Confidence In Vitro >10 YearsHuman somatic cell experiments reported induction of telomerase activity and increased telomere length under the studied conditions. [PMID: 12937682]
Safety & Unknowns
- Human clinical safety and efficacy are not established by cell-culture studies.
- Nomenclature and identity confusion increases misinterpretation risk; primary-source verification matters.
Regulatory Status
| Region | Status |
|---|---|
| United States (FDA) | Not approved |
| European Union (EMA) | Not approved |
| WADA | Check current list (status may change) |
Changelog
| Date | Change |
|---|---|
| 2026-01-23 | Added dossier and linked primary literature |